Home
Most women experience decreased menstrual blood loss, with a significant number experiencing amenorrhea, which is safe.
Mean number of bleeding/spotting days by 30-day reference periods in phase III trials (1-year period)
More information available here
Black D. and Waddington A. et al. Build Your Expertise: IUC
slide deck: 84.
Costescu et al. Levonorgestrel-Releasing Intrauterine
Systems for Long-Acting Contraception: Current Perspectives,
Safety, and Patient Counseling.Int J Womens Health 2016.
SOGC Clinical Practice Guideline, Canadian Contraception Consensus
(part 3): Chapter 7 – Intrauterine Contraception